Yuefeng Shang
Overview
Explore the profile of Yuefeng Shang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
1
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Xie C, Chan L, Pang Y, Shang Y, Wang W, Zhao L
Naunyn Schmiedebergs Arch Pharmacol
. 2025 Feb;
PMID: 39998626
Breast cancer is the most common malignant tumor in women. Among its subtypes, triple-negative breast cancer (TNBC) is more aggressive and poses a serious threat to women's health. Rosmarinic acid...
2.
Shang Y, Liu T, Wang W
Med Oncol
. 2024 Aug;
41(9):233.
PMID: 39172293
Breast cancer, as a highly prevalent cancer among women, is one of the main causes of female mortality due to cancer. There is a need for more treatment options to...
3.
Xie C, Chan L, Pang Y, Shang Y, Cao W, Tuohan M, et al.
Biomed Pharmacother
. 2024 Jul;
178:117158.
PMID: 39042963
Triple-negative breast cancer (TNBC) still one of the most challenging sub-type in breast cancer clinical. Caffeic acid (CA) derived from effective components of traditional Chinese herbal medicine has been show...
4.
Liu S, Li X, Zhang Y, Deng Y, Li Z, Zhu Y, et al.
Heliyon
. 2024 Jul;
10(12):e33219.
PMID: 39022007
Background: Breast cancer is the most widespread malignant tumor worldwide. Single-cell sequencing technology offers novel insights and methods to understand the onset, progression, and treatment of tumors. Nevertheless, there is...
5.
Ma J, Pang Y, Shang Y, Xie C, Xu X, Chan L, et al.
Clin Immunol
. 2024 Apr;
263:110227.
PMID: 38643891
T-DM1 (Trastuzumab Emtansine) belongs to class of Antibody-Drug Conjugates (ADC), where cytotoxic drugs are conjugated with the antibody Trastuzumab to specifically target HER2-positive cancer cells. Platelets, as vital components of...
6.
Li J, Zhang H, Shang Y, Cao S
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue
. 2014 Apr;
26(4):269-71.
PMID: 24709501
No abstract available.